In vitro cytotoxicity of imidazolyl-1,3,5-triazine derivatives

Biological and Pharmaceutical Bulletin

Volumn 20, Issue 6, 1997, Pages 698-700

  Yaguchi, Shin Ichi ^a   Izumisawa, Yasuhiro ^a   Sato, Makoto ^a   Nakagane, Tsutomu ^a   Koshimizu, Ichiro ^a   Sakita, Katsuyasu ^a   Kato, Masanobu ^a   Yoshioka, Kimitomo ^a   Sakato, Mitsuo ^a   Kawashima, Seiichiro ^a  

^a ZENYAKU KOGYO CO LTD   (Japan)

Author keywords

Cytotoxicity; Hexamethylmelamine; Hydroxymethylpentamethylmelamine; Imidazolyl 1,3,5 triazine

Indexed keywords

2 (1 IMIDAZOLYL) 4 (N METHYL N PHENYLAMINO) 6 MORPHINO 1,3,5 TRIAZINE; 2 (1 IMIDAZOLYL) 4 MORPHOLINO 6 (3 THIAZOLIDINYL) 1,3,5 TRIAZINE; 2 (1 IMIDAZOLYL) 4,6 BIS(MORPHOLINO) 1,3,5 TRIAZINE; 2 (4 CYANO 4 PHENYLPIPERIDINO) 4 (1 IMIDAZOLYL) 6 MORPHOLINO 1,3,5 TRIAZINE; ALTRETAMINE; FADROZOLE; IMIDAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CYTOTOXICITY; HUMAN; HUMAN CELL; MOUSE; MURINE LEUKEMIA; NONHUMAN;

EID: 18544404747     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.20.698     Document Type: Article

References (13)

1. Matsuno T., Kato M., Tsuchida Y., Takahashi M., Terada S., Chem. Pharm. Bull. 45, 291-296 (1997).
2. Wilson W. L., Bisel H. F., Cole D., Rochlin D., Ramirez G., Madden R., Cancer, 25, 568-570 (1970).
3. Legha S. S., Slavik M., Carter S. K., Cancer, 38, 27-35 (1976).
4. Foster B. J., Harding B. J., Leyland-Jones B., Hoth D., Cancer Treat. Rev., 113, 197-217 (1986).
5. Blum R. H., Livingston R. B., Carter S. K., Eur. J. Cancer, 9, 195-202 (1973).
6. Boven E., Nauta M. M., Schlüper H. M. M., Erkelens C. A. M., Pinedo H., Cancer Chemother. Pharmacol., 18, 124-128 (1986).
7. Tanino H., Kubota T., Yamada Y., Koh J., Kase S., Furukawa T., Kuo T.-H., Saikawa Y., Kitajima M., Naito Y., Jpn. J. Cancer Res., 86, 770-775 (1995).
8. Rutty C. J., Connors T. A., Biochem. Pharmacol., 26, 2385-2391 (1977).
9. Gescher A., D'Incalci M., Fanelli R., Farina P., Life Sci., 26, 147-154 (1980).
10. Tanino H., Kubota T., Yamada Y., Koh J., Takeuchi T., Kase S., Furukawa T., Takahashi M., Fukuda S., Ogose N., Komatsu T., Kato M., Kitajima M., Sakurai T., Naito Y., Hoffman R. M., Anticancer Res., 13, 623-626 (1993).
11. Mosmann T., J. Immunol. Methods, 65, 55-63 (1983).
12. Dubois J., Arnold R., Abikhalil F., Hanocq M., Atassi G., Ghanem G., Libert A., Lejeune F. J., Anticancer Res., 10, 827-832 (1990).
13. Yano S., Tanaka M., Nakao K., Eur. J. Pharmacol., 289, 217-222 (1995).